Sigma Healthcare : Change of Director's Interest Notice

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	SIGMA HEALTHCARE LIMITED
ABN	15 088 417 403
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director		Christine BARTLETT
Date of last notice		07/04/2022

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

	Direct or indirect interest	Direct
	Nature of indirect interest	CN Bartlett and KR Coles Super Fund
	(including r g stered holder)
	Note: Provide details of the circumstances giving rise to the relevant
	interest.	14/07/2022
	Date of change
		Direct - 190,654
	No. of securities held prior to change	250,654
	Class	Indirect - 60,000
		FPO
	Number acquired	9,217
	Number disposed	$5,286.87
	Note: If consideration is non-cash, provide details and estimated
	Value/Considerat on
	valuation
		Direct - 199,871
	No. of securities held after change	259,871
		Indirect - 60,000
	+ See chapter 19 for defined terms.	Appendix 3Y Page 1
01/01/2011

For personal use only

Appendix 3Y

Change of Director's Interest Notice

	Example:Natureonof-marketchangetrade,off-market trade, exercise of options, issue		Shares purchased under NED's Share Plan
	of securities under dividend reinvestment plan, participation in buy-
	back

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which

Note:interestDetailsrelatedare only priorrequiredtoforchangea contract in relation to which the interest has changed

Interest acquired

Interest disposed

Note:Value/ConsiderationIf consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.	01/01/2011
Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	SIGMA HEALTHCARE LIMITED
ABN	15 088 417 403
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director		David Gerald MANUEL
Date of last notice		01/04/2022

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

	Direct or indirect interest	Direct
	Nature of indirect interest
	Note: Provide details of the circumstances giving rise to the relevant
	(including r g stered holder)
	interest.	14/07/2022
	Date of change
	Class	Direct - 358,726
	No. of securities held prior to change	358,726
		FPO
	Number acquired	8,641
	Number disposed	$4,956.48
	Note: If consideration is non-cash, provide details and estimated
	Value/Considerat on
	valuation
	No. of securities held after change	Direct - 367,367
	367,367
	+ See chapter 19 for defined terms.	Appendix 3Y Page 1
01/01/2011

For personal use only

Appendix 3Y

Change of Director's Interest Notice

	Example:Natureonof-marketchangetrade,off-market trade, exercise of options, issue		Shares purchased under NED's Share Plan
	of securities under dividend reinvestment plan, participation in buy-
	back

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which

Note:interestDetailsrelatedare only priorrequiredtoforchangea contract in relation to which the interest has changed

Interest acquired

Interest disposed

Note:Value/ConsiderationIf consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.	01/01/2011
Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	SIGMA HEALTHCARE LIMITED
ABN	15 088 417 403
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director		Kathryn SPARGO
Date of last notice		16/05/2022

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

	Direct or indirect interest
	Note: Provide details of the circumstances giving rise to the relevant	Director Spargo Super Pty Ltd (atf Spargo
	Nature of indirect interest	Direct
	(including r g stered holder)	Self-managed superannuation fund of
	Date of change	Super Fund)
	interest.	14/07/2022
		Direct - 182,881
	No. of securities held prior to change	422,881
	Class	Indirect - 240,000
		FPO
	Number acquired
		8,641
	Number disposed	$4,956.48
	Note: If consideration is non-cash, provide details and estimated
	Value/Considerat on
	valuation
		Direct - 191,522
	No. of securities held after change	431,522
		Indirect - 240,000
	+ See chapter 19 for defined terms.	Appendix 3Y Page 1
01/01/2011